248 related articles for article (PubMed ID: 11957018)
1. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.
Bernabeu-Wittel M; Naranjo M; Cisneros JM; Cañas E; Gentil MA; Algarra G; Pereira P; González-Roncero FJ; de Alarcón A; Pachón J
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):173-80. PubMed ID: 11957018
[TBL] [Abstract][Full Text] [Related]
2. Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients?
Prokopenko E; Scherbakova E; Vatazin A; Pasov S; Budnikova N; Agafonova S
Drugs Exp Clin Res; 2005; 31(5-6):199-205. PubMed ID: 16425976
[TBL] [Abstract][Full Text] [Related]
3. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
Basic-Jukic N; Kes P; Bubic-Filipi LJ; Puretic Z; Brunetta B; Pasini J
Transplant Proc; 2005 Mar; 37(2):850-1. PubMed ID: 15848553
[TBL] [Abstract][Full Text] [Related]
4. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.
Bataille S; Moal V; Gaudart J; Indreies M; Purgus R; Dussol B; Zandotti C; Berland Y; Vacher-Coponat H
Transpl Infect Dis; 2010 Dec; 12(6):480-8. PubMed ID: 20629971
[TBL] [Abstract][Full Text] [Related]
6. Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids.
Cristelli MP; Tedesco-Silva H; Medina-Pestana JO; Franco MF
Transpl Infect Dis; 2013 Aug; 15(4):369-78. PubMed ID: 23701592
[TBL] [Abstract][Full Text] [Related]
7. Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.
Sarmiento JM; Munn SR; Paya CV; Velosa JA; Nguyen JH
Clin Transplant; 1998 Oct; 12(5):371-4. PubMed ID: 9787943
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of azathioprine versus mycophenolate mofetil in cyclosporine-based immunosuppression in kidney transplantation: 10 years of experience at a single center.
Kwon O; Cho JH; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transplant Proc; 2013 May; 45(4):1487-90. PubMed ID: 23726603
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
[TBL] [Abstract][Full Text] [Related]
10. [Infectious complications in using mofetil micofenolate in patients with renal allotransplant].
Prokopenko EI; Shcherbakova EO; Vatazin AV; Kruglov EE; Pasov SA; Budnikova NE; Agafonova SG; Rusanova EV
Ter Arkh; 2005; 77(1):67-72. PubMed ID: 15759459
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
12. Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?
Johnson DW; Nicol DL; Purdie DM; Preston JM; Brown AM; Hawley CM; Campbell SB; Wall D; Griffin AD; Isbel NM
Transplantation; 2002 Apr; 73(7):1158-63. PubMed ID: 11965051
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
16. The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.
Satoh S; Tada H; Murakami M; Tsuchiya N; Inoue T; Togashi H; Matsuura S; Hayase Y; Suzuki T; Habuchi T
Transplant Proc; 2005 May; 37(4):1751-3. PubMed ID: 15919454
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group.
Staskewitz A; Kirste G; Tönshoff B; Weber LT; Böswald M; Burghard R; Helmchen U; Brandis M; Zimmerhackl LB
Transplantation; 2001 Mar; 71(5):638-44. PubMed ID: 11292293
[TBL] [Abstract][Full Text] [Related]
19. Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil.
Kimball JA; Pescovitz MD; Book BK; Norman DJ
Transplantation; 1995 Dec; 60(12):1379-83. PubMed ID: 8545860
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
Sterneck M; Fischer L; Gahlemann C; Gundlach M; Rogiers X; Broelsch C
Ann Transplant; 2000; 5(1):43-6. PubMed ID: 10850611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
